Join PharmQD!

Become a member of our interactive community. Collaborate and network with your colleagues and trusted peers. Membership is free!

Communicate and Educate

Discuss new and important issues with your colleagues. Share your insights to help improve patient counseling.

Network With Peers

Join the conversation with trusted colleagues. Link up with professionals who share your ideas and insights.

Learn and Advance

Take free CE courses and rate courses for your peers. Find and apply for the newest jobs. Stay up-to-date on pharmacy news.

Unite

Share your experience with pharmacy students and technicians.

Create an account and receive access to the personalized box below, including your profile, bookmarks, friends, posts and more!

Join Now!

PharmNews

Featured News

Benefits of e-Cigarettes Outweigh Harms, Current Evidence Suggests - 08.01.2014

A major scientific review of available research on the use, content, and safety of e-cigarettes has concluded that -- although long-term health effects of e-cigarette use are unknown -- compared with conventional cigarettes they are likely to be much less harmful to users or bystanders.More »

Featured News

C. Difficile Vaccine Proves Safe, 100 Percent Effective in Animal Models - 08.01.2014

An experimental vaccine protected 100 percent of animal models against the highly infectious and virulent bacterium, Clostridium difficile, which causes an intestinal disease that kills approximately 30,000 Americans annually. The research is published ahead of print in Infection and Immunity.More »

Featured News

Naltrexone May be Effective in Diminishing Impulse Control Disorders in Parkinson's Disease Patients - 07.30.2014

Up to 20 percent of Parkinson's disease (PD) patients and their families may confront a common but largely unrecognized challenge: the occurrence of impulse control disorders (ICDs) such as compulsive gambling, sexual behavior, eating, or spending. Yet the presence of PD in these patients can severely limit or complicate treatment options. A team of investigators from the Perelman School of Medicine at the University of Pennsylvania and the Parkinson's Disease Research, Education and Clinical Center (PADRECC) at the Philadelphia Veterans Affairs Medical Center conducted a pilot study and found that the opioid antagonist naltrexone may be an effective treatment for diminishing ICD symptoms in PD patients. The results were published in the journal Neurology.More »

Featured News

Drugs used to treat lung disease work with body clock - 07.28.2014

Scientists from The University of Manchester have discovered why medication to treat asthma and pneumonia can become ineffective. The findings, published in Nature Medicine, show that drugs widely used to treat lung diseases work with the body clock.More »

Featured News

Statin use decreases risk of Barrett's esophagus, study shows - 07.25.2014

Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. Obese patients experienced the greatest level of risk reduction with statin use.More »

Advertisement

PharmTalk

New Blog Postings

Other Blog Posts

Pharmacist dispensed M&Ms instead of pain pills 06.25.14 jessevivian
Too Little, Too Late 06.19.14 1 comment nyrxman
The Ethical Pharmacist 05.20.14 3 comments nyrxman
Advice-Caution! 05.18.14 txrelief